- Tytuł:
- Evaluating the efficacy and safety of pozelimab in patients with CD55 deficiency with hyperactivation of complement, angiopathic thrombosis, and protein-losing enteropathy disease: an open-label phase 2 and 3 study
- Autorzy:
- Źródło:
- In The Lancet 17-23 February 2024 403(10427):645-656
Czasopismo naukowe